Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michał Zabojszcz is active.

Publication


Featured researches published by Michał Zabojszcz.


Kardiologia Polska | 2013

Electrocardiographic landmarks of hypothermia

Piotr Kukla; Adrian Baranchuk; Marek Jastrzębski; Michał Zabojszcz; Leszek Bryniarski

We present the cases of two patients with hypothermia, with a detailed description of electrocardiographic changes associated with hypothermia. In both cases, J wave was initially misdiagnosed as left bundle branch block (LBBB). We discuss the differentiation of J wave from LBBB.


Blood Pressure | 2006

Rilmenidine – its antihypertensive efficacy, safety and impact on quality of life in perimenopausal women with mild to moderate essential hypertension

Kalina Kawecka-Jaszcz; Danuta Czarnecka; Marek Klocek; Michał Zabojszcz; Marta Kucharska; Rafał Jaworski; Robert Pachocki

Objectives. A prospective, open‐labeled study to assess the antihypertensive effect of monotherapy with rilmenidine and its impact on quality of life (QoL), as well as on biochemical parameters in perimenopausal women with essential hypertension. Design and methods. Fifty‐five perimenopausal women with mild to moderate essential hypertension (mean age 51.4±2.4 years) were enrolled. At baseline and after 12‐week monotherapy with rilmenidine, we assessed: systolic (SBP) and diastolic (DBP) blood pressure (BP), heart rate (HR), fasting glucose, serum creatinine and total cholesterol levels. QoL was also assessed at baseline and at 12 weeks by two standardized questionnaires: the Short Form – 36 (SF‐36) and the Subjective Symptoms Assessment Profile (SSAP). Statistical analysis was performed using Students t‐test to compare changes in BP, QoL and biochemical parameters during therapy with rilmenidine. Results. After 12 weeks of therapy, there was a significant decrease in BP and HR. Normalization of BP was observed in 46 (84%) women. Rilmenidine did not influence serum creatinine, fasting glucose and lipid profile. Treatment was very well tolerated by the patients and no side‐effects were noted. Both the SF‐36 and the SSAP demonstrated improvement in general QoL. We observed a significant improvement in all SF‐36 subscales. In the SSAP, a similar significant improvement was found, except dizziness subscale. Improvement in QoL was not related to reduction of BP. Conclusions. Monotherapy with rilmenidine is safe and effective in BP treatment and significantly improves QoL in perimenopausal women with essential hypertension.


Cardiology Journal | 2017

Treatment of coronary chronic total occlusion by transradial approach: Current trends and expert recommendations

Leszek Bryniarski; Michał Zabojszcz; Krzysztof Bryniarski

The aim of this review is to highlight the technical details and the scientific data on percutaneous coronary interventions (PCIs) in chronic total occlusion (CTO) performed by transradial approach (TRA). Transfemoral approach (TFA) is commonly regarded as the standard for CTO PCI, but there is a growing number of CTO recanalization procedures performed by TRA. We discuss the relevant technical details to approach a CTO by transradial access, especially the compatibility of various CTO recanalization techniques with specific guiding catheter sizes. Randomized prospective trials in this field are lacking and only data from observational studies are available. We can conclude that transradial access for CTO PCI is feasible and could be very useful in selected patients. In our opinion, transradial access in CTO PCIs should be limited to operators and centers highly experienced in CTO recanaliza¬tion and in TRA.


Cardiology Journal | 2009

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies

Leszek Bryniarski; Agnieszka Pelc-Nowicka; Michał Zabojszcz; Ewa Mirek-Bryniarska


Kardiologia Polska | 2011

Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation.

Michał Owsiak; Agnieszka Pelc-Nowicka; Leszek Badacz; Jacek S. Dubiel; Dariusz Dudek; Grzegorz Gajos; Janusz Grodecki; Piotr Jankowski; Kalina Kawecka-Jaszcz; Ewa Mirek-Bryniarska; Jadwiga Nessler; Piotr Podolec; Jerzy Sadowski; Wiesława Tracz; Michał Zabojszcz; Krzysztof Żmudka; Leszek Bryniarski


Kardiologia Polska | 2009

Original article Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome - does everyday medical practice reflects current recommendations? A pilot study

Agnieszka Pelc-Nowicka; Leszek Bryniarski; Ewa Mirek-Bryniarska; Michał Zabojszcz


Advances in Interventional Cardiology | 2010

Original paper Knowledge about chronic total coronary artery occlusions among Polish physicians

Leszek Bryniarski; Michał Zabojszcz; Krzysztof Bryniarski; Michał Terlecki


Kardiologia Polska | 2011

[Patient with left ventricular aneurysm and thrombus after myocardial infarction - long-term observation].

Agnieszka Kwiecień-Sobstel; Michał Zabojszcz; Michał Owsiak; Stanisław Bartuś; Dariusz Dudek; Kalina Kawecka-Jaszcz; Ewa Mirek-Bryniarska; Leszek Bryniarski


Folia Cardiologica | 2004

Angioplastyka w miejscach rozgałęzień naczyń wieńcowych - doświadczenie własne

Leszek Bryniarski; Dariusz Dudek; Jacek Dragan; Artur Klecha; Piotr Jankowski; Tadeusz Królikowski; Danuta Czarnecka; Michał Zabojszcz; Marek Styczkiewicz; Krzysztof Żmudka i Kalina Kawecka-Jaszcz


Interventional Cardiology | 2015

Retrograde approach to chronically occluded coronary arteries – a step forward in CTO PCI

Leszek Bryniarski; Sławomir Surowiec; Michał Zabojszcz

Collaboration


Dive into the Michał Zabojszcz's collaboration.

Top Co-Authors

Avatar

Leszek Bryniarski

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Kalina Kawecka-Jaszcz

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Dariusz Dudek

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Piotr Jankowski

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Danuta Czarnecka

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Artur Klecha

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Jacek Dragan

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Tadeusz Królikowski

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Bryniarski

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Marek Rajzer

Jagiellonian University Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge